<?xml version='1.0' encoding='UTF-8'?>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Sci Rep</journal-id>
      <journal-id journal-id-type="iso-abbrev">Sci Rep</journal-id>
      <journal-title-group>
        <journal-title>Scientific Reports</journal-title>
      </journal-title-group>
      <issn pub-type="epub">2045-2322</issn>
      <publisher>
        <publisher-name>Nature Publishing Group UK</publisher-name>
        <publisher-loc>London</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">31537890</article-id>
      <article-id pub-id-type="pmc">6753205</article-id>
      <article-id pub-id-type="publisher-id">50024</article-id>
      <article-id pub-id-type="doi">10.1038/s41598-019-50024-3</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Elucidating the putative link between prefrontal neurotransmission, functional connectivity, and affective symptoms in irritable bowel syndrome</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Icenhour</surname>
            <given-names>Adriane</given-names>
          </name>
          <address>
            <email>adriane.icenhour@uk-essen.de</email>
          </address>
          <xref ref-type="aff" rid="Aff1">1</xref>
          <xref ref-type="aff" rid="Aff2">2</xref>
          <xref ref-type="aff" rid="Aff6">6</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Tapper</surname>
            <given-names>Sofie</given-names>
          </name>
          <xref ref-type="aff" rid="Aff2">2</xref>
          <xref ref-type="aff" rid="Aff3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Bednarska</surname>
            <given-names>Olga</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Witt</surname>
            <given-names>Suzanne T.</given-names>
          </name>
          <xref ref-type="aff" rid="Aff2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Tisell</surname>
            <given-names>Anders</given-names>
          </name>
          <xref ref-type="aff" rid="Aff2">2</xref>
          <xref ref-type="aff" rid="Aff4">4</xref>
          <xref ref-type="aff" rid="Aff5">5</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lundberg</surname>
            <given-names>Peter</given-names>
          </name>
          <xref ref-type="aff" rid="Aff2">2</xref>
          <xref ref-type="aff" rid="Aff4">4</xref>
          <xref ref-type="aff" rid="Aff5">5</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Elsenbruch</surname>
            <given-names>Sigrid</given-names>
          </name>
          <xref ref-type="aff" rid="Aff6">6</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Walter</surname>
            <given-names>Susanna</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
          <xref ref-type="aff" rid="Aff2">2</xref>
        </contrib>
        <aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2162 9922</institution-id><institution-id institution-id-type="GRID">grid.5640.7</institution-id><institution>Department of Gastroenterology and Department of Clinical and Experimental Medicine, </institution><institution>Linköping University, </institution></institution-wrap>Linköping, Sweden </aff>
        <aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2162 9922</institution-id><institution-id institution-id-type="GRID">grid.5640.7</institution-id><institution>Center for Medical Image Science and Visualization (CMIV), </institution><institution>Linköping University, </institution></institution-wrap>Linköping, Sweden </aff>
        <aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2162 9922</institution-id><institution-id institution-id-type="GRID">grid.5640.7</institution-id><institution>Department of Medical and Health Sciences, </institution><institution>Linköping University, </institution></institution-wrap>Linköping, Sweden </aff>
        <aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2162 9922</institution-id><institution-id institution-id-type="GRID">grid.5640.7</institution-id><institution>Department of Radiation Physics, Department of Medical and Health Sciences, </institution><institution>Linköping University, </institution></institution-wrap>Linköping, Sweden </aff>
        <aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2162 9922</institution-id><institution-id institution-id-type="GRID">grid.5640.7</institution-id><institution>Department of Radiology, Department of Medical and Health Sciences, </institution><institution>Linköping University, </institution></institution-wrap>Linköping, Sweden </aff>
        <aff id="Aff6"><label>6</label>Institute of Medical Psychology and Behavioral Immunobiology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany </aff>
      </contrib-group>
      <pub-date pub-type="epub">
        <day>19</day>
        <month>9</month>
        <year>2019</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>19</day>
        <month>9</month>
        <year>2019</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2019</year>
      </pub-date>
      <volume>9</volume>
      <elocation-id>13590</elocation-id>
      <history>
        <date date-type="received">
          <day>4</day>
          <month>2</month>
          <year>2019</year>
        </date>
        <date date-type="accepted">
          <day>15</day>
          <month>8</month>
          <year>2019</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>© The Author(s) 2019</copyright-statement>
        <license license-type="OpenAccess">
          <license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p>
        </license>
      </permissions>
      <abstract id="Abs1">
        <p id="Par1">Altered neural mechanisms are well-acknowledged in irritable bowel syndrome (IBS), a disorder of brain-gut-communication highly comorbid with anxiety and depression. As a key hub in corticolimbic inhibition, medial prefrontal cortex (mPFC) may be involved in disturbed emotion regulation in IBS. However, aberrant mPFC excitatory and inhibitory neurotransmission potentially contributing to psychological symptoms in IBS remains unknown. Using quantitative magnetic resonance spectroscopy (qMRS), we compared mPFC glutamate + glutamine (Glx) and γ-aminobutyric acid (GABA+) concentrations in 64 women with IBS and 32 age-matched healthy women (HCs) and investigated their association with anxiety and depression in correlational and subgroup analyses. Applying functional magnetic resonance imaging (fMRI), we explored whether altered neurotransmission was paralleled by aberrant mPFC resting-state functional connectivity (FC). IBS patients did not differ from HCs with respect to mPFC GABA+ or Glx levels. Anxiety was positively associated with mPFC GABA+ concentrations in IBS, whereas Glx was unrelated to psychological or gastrointestinal symptoms. Subgroup comparisons of patients with high or low anxiety symptom severity and HCs revealed increased GABA+ in patients with high symptom severity, and lower mPFC FC with adjacent anterior cingulate cortex (ACC), a crucial region of emotion modulation. Our findings provide novel evidence that altered prefrontal inhibitory neurotransmission may be linked to anxiety in IBS.</p>
      </abstract>
      <kwd-group kwd-group-type="npg-subject">
        <title>Subject terms</title>
        <kwd>Human behaviour</kwd>
        <kwd>Comorbidities</kwd>
      </kwd-group>
      <funding-group>
        <award-group>
          <funding-source>
            <institution-wrap>
              <institution-id institution-id-type="FundRef">https://doi.org/10.13039/501100001659</institution-id>
              <institution>Deutsche Forschungsgemeinschaft (German Research Foundation)</institution>
            </institution-wrap>
          </funding-source>
          <award-id>IC 81/1-1</award-id>
          <award-id>project number 316803389 – SFB 1280</award-id>
          <principal-award-recipient>
            <name>
              <surname>Icenhour</surname>
              <given-names>Adriane</given-names>
            </name>
            <name>
              <surname>Elsenbruch</surname>
              <given-names>Sigrid</given-names>
            </name>
          </principal-award-recipient>
        </award-group>
      </funding-group>
      <funding-group>
        <award-group>
          <funding-source>
            <institution-wrap>
              <institution-id institution-id-type="FundRef">https://doi.org/10.13039/501100004063</institution-id>
              <institution>Knut och Alice Wallenbergs Stiftelse (Knut and Alice Wallenberg Foundation)</institution>
            </institution-wrap>
          </funding-source>
        </award-group>
      </funding-group>
      <funding-group>
        <award-group>
          <funding-source>
            <institution>Kurt and Helena Widéns Research fund</institution>
          </funding-source>
        </award-group>
      </funding-group>
      <funding-group>
        <award-group>
          <funding-source>
            <institution-wrap>
              <institution-id institution-id-type="FundRef">https://doi.org/10.13039/501100002706</institution-id>
              <institution>AFA Försäkring (AFA Insurance Foundation)</institution>
            </institution-wrap>
          </funding-source>
        </award-group>
      </funding-group>
      <funding-group>
        <award-group>
          <funding-source>
            <institution-wrap>
              <institution-id institution-id-type="FundRef">https://doi.org/10.13039/501100009336</institution-id>
              <institution>Bengt Ihres Foundation</institution>
            </institution-wrap>
          </funding-source>
        </award-group>
      </funding-group>
      <funding-group>
        <award-group>
          <funding-source>
            <institution>County Council Östergötland</institution>
          </funding-source>
        </award-group>
      </funding-group>
      <custom-meta-group>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>© The Author(s) 2019</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <sec id="Sec1" sec-type="introduction">
      <title>Introduction</title>
      <p id="Par2">The relevance of bidirectional communication pathways between the brain and the gastrointestinal system, the brain-gut-axis, is increasingly acknowledged in health and in the pathophysiology of various somatic and neuropsychiatric disturbances<sup><xref ref-type="bibr" rid="CR1">1</xref></sup>. Irritable bowel syndrome (IBS) is considered an exemplary disorder of brain-gut communication. Cardinal symptoms of the heterogeneous disease are gastrointestinal in nature, yet psychiatric comorbidities particularly with anxiety and depression affect a large proportion of IBS patients<sup><xref ref-type="bibr" rid="CR2">2</xref>,<xref ref-type="bibr" rid="CR3">3</xref></sup>, with profound clinical implications<sup><xref ref-type="bibr" rid="CR4">4</xref>–<xref ref-type="bibr" rid="CR6">6</xref></sup>. While this key role of psychological symptoms in altered brain-gut communication is increasingly appreciated, distinct neural correlates of anxiety and depression symptoms in IBS are only beginning to be elucidated.</p>
      <p id="Par3">Functional magnetic resonance imaging (fMRI) studies frequently demonstrate aberrant brain function involving regions associated with emotion processing and regulation in IBS<sup><xref ref-type="bibr" rid="CR7">7</xref></sup>. Within these circuits, the medial prefrontal cortex (mPFC) including rostral anterior cingulate cortex (rACC) is among the regions with most consistently observed functional alterations<sup><xref ref-type="bibr" rid="CR7">7</xref>,<xref ref-type="bibr" rid="CR8">8</xref></sup>. The mPFC represents a key node in emotion regulation and top-down corticolimbic inhibitory control<sup><xref ref-type="bibr" rid="CR9">9</xref></sup>. In line with this, observed changes in mPFC function in IBS are reportedly associated with symptoms of anxiety and depression<sup><xref ref-type="bibr" rid="CR10">10</xref>–<xref ref-type="bibr" rid="CR12">12</xref></sup>. Dysfunctional prefrontal inhibitory control may therefore be a crucial mechanism underlying aberrant emotion regulation and psychological symptoms in IBS. Notwithstanding these well-documented functional mPFC alterations in IBS, their putative neurochemical basis remains largely unknown.</p>
      <p id="Par4">As crucial biochemical markers of brain tissue excitation and inhibition<sup><xref ref-type="bibr" rid="CR13">13</xref></sup>, glutamate (Glu, often reported as a combined glutamate + glutamine measurement, Glx) and γ-aminobutyric acid (GABA, commonly reported with a co-edited macromolecular signal as GABA+<sup><xref ref-type="bibr" rid="CR14">14</xref></sup>) may be key players in altered brain function in IBS. A previous quantitative magnetic resonance spectroscopy (qMRS) study described reductions of hippocampal Glu<sup><xref ref-type="bibr" rid="CR15">15</xref></sup> and recent findings document lower Glx concentrations in bilateral insulae in IBS patients<sup><xref ref-type="bibr" rid="CR16">16</xref></sup>, extending evidence of aberrant neurotransmission assessed from different brain regions in pelvic pain<sup><xref ref-type="bibr" rid="CR17">17</xref></sup> and fibromyalgia<sup><xref ref-type="bibr" rid="CR18">18</xref></sup>, diseases highly comorbid with IBS<sup><xref ref-type="bibr" rid="CR2">2</xref></sup>. Reported associations between neurotransmitter concentrations and psychological symptoms<sup><xref ref-type="bibr" rid="CR15">15</xref>,<xref ref-type="bibr" rid="CR18">18</xref>,<xref ref-type="bibr" rid="CR19">19</xref></sup> lend first support for a relation between psychological factors and central alterations, even on a biochemical level. These data are substantiated by altered biochemistry within different target regions observed in patients with anxiety disorders and depression<sup><xref ref-type="bibr" rid="CR20">20</xref>–<xref ref-type="bibr" rid="CR22">22</xref></sup>. Finally, recent data document a link between anxiety, increased mPFC GABA+ concentrations and changes in functional connectivity (FC) in healthy volunteers<sup><xref ref-type="bibr" rid="CR23">23</xref>,<xref ref-type="bibr" rid="CR24">24</xref></sup>, supporting a distinct role of increased prefrontal GABA in disturbed corticolimbic inhibition<sup><xref ref-type="bibr" rid="CR25">25</xref></sup>. A dysregulation of prefrontal inhibitory control, possibly due to an abundance of GABA inhibiting regulatory circuits, may thus be involved in aberrant emotion regulation and increased psychological complaints<sup><xref ref-type="bibr" rid="CR25">25</xref></sup>, which remains to be elucidated in patients with IBS.</p>
      <p id="Par5">In this combined qMRS and resting-state fMRI study, we therefore aimed to investigate mPFC Glx and GABA+ concentrations and their relation to psychological as well as gastrointestinal symptoms in female patients with IBS and age-matched healthy women. We hypothesized IBS patients to exhibit dysregulated mPFC neurotransmitter levels, particularly increased GABA+. We further expected symptoms of anxiety and/or depression to be related to aberrant prefrontal neurotransmitter concentrations and tested in subgroup analyses, whether biochemical alterations were most pronounced in patients with high severity of anxiety/depression. Finally, we explored FC of mPFC with amygdala as a core node of corticolimbic circuitry<sup><xref ref-type="bibr" rid="CR24">24</xref>,<xref ref-type="bibr" rid="CR25">25</xref></sup>, and with insula and ACC as key players in emotion processing and modulation with a crucial role in both, anxiety<sup><xref ref-type="bibr" rid="CR26">26</xref></sup> and IBS<sup><xref ref-type="bibr" rid="CR7">7</xref>,<xref ref-type="bibr" rid="CR8">8</xref></sup>. We hypothesized disrupted connectivity within these circuits particularly in patients with a high severity of anxiety/depression.</p>
    </sec>
    <sec id="Sec2" sec-type="results">
      <title>Results</title>
      <sec id="Sec3">
        <title>Sample characteristics</title>
        <p id="Par6">Patients presented with moderate to severe IBS and were characterized by greater symptom-specific anxiety, higher pain intensity, and more interference compared to HCs (all <italic>p</italic> &lt; 0.001; Supplementary Table <xref rid="MOESM1" ref-type="media">S1</xref>). Patients further exhibited higher severity of anxiety and depression symptoms (all <italic>p</italic> &lt; 0.001).</p>
      </sec>
      <sec id="Sec4">
        <title>Between-group comparisons of mPFC neurotransmitter levels</title>
        <p id="Par7">Compared to HCs, IBS patients in general did not show significant differences in concentrations of either mPFC GABA+ (<italic>U</italic> = 933.50; <italic>p</italic> = 0.488) or Glx (<italic>U</italic> = 979.50; <italic>p</italic> = 0.728) (Fig. <xref rid="Fig1" ref-type="fig">1</xref>). Notably, a proportion of patients used selective serotonin-reuptake inhibitors or low-dose tricyclic antidepressants at the time of participation. To exclude potential confounding effects of centrally-acting medication, we conducted additional between-group analyses of qMRS data including only patients free from antidepressants (N = 43). Results confirmed no between-group differences in GABA+ or Glx concentrations (Supplementary Notes <xref rid="MOESM1" ref-type="media">S2a</xref>). Exploratory analyses of mPFC total N-acetylaspartate (tNA), Creatine (tCr) and Choline (Cho) further revealed no differences between patients and controls (all <italic>p</italic> &gt; 0.10; Supplementary Table <xref rid="MOESM1" ref-type="media">S3</xref>).<fig id="Fig1"><label>Figure 1</label><caption><p>Group comparisons of mPFC GABA+ (<bold>A</bold>) and Glx (<bold>B</bold>) concentrations in HCs (N = 32; blue) and patients with IBS (N = 64; red). Data are shown as median and error bars indicate interquartile ranges.</p></caption><graphic xlink:href="41598_2019_50024_Fig1_HTML" id="d30e513"/></fig></p>
      </sec>
      <sec id="Sec5">
        <title>Associations between neurotransmitter concentrations and psychological symptoms</title>
        <p id="Par8">Correlational analyses in the full sample (Supplementary Table <xref rid="MOESM1" ref-type="media">S4</xref>) and in patients and HCs separately were conducted to investigate whether concentrations of mPFC neurotransmitters were associated with symptoms of anxiety and depression. We further explored associations with disease-related measures, such as symptom severity, pain intensity and interference, and GI symptom-specific anxiety to estimate the relative specificity of our findings to psychological symptoms. Briefly, in the full sample GABA+ concentrations were most strongly associated with anxiety symptoms (<italic>r</italic><sub><italic>s</italic></sub> = 0.264; <italic>p</italic> = 0.009; Fig. <xref rid="Fig2" ref-type="fig">2A</xref>) and showed weaker correlations with symptoms of depression (<italic>r</italic><sub><italic>s</italic></sub> = 0.207; <italic>p</italic> = 0.044, Fig. <xref rid="Fig2" ref-type="fig">2B</xref>), whereas Glx was not associated with psychological symptoms. Analyses conducted in IBS patients and HCs separately substantiated a distinct association between mPFC GABA+ concentrations and anxiety in patients (<italic>r</italic><sub><italic>s</italic></sub> = 0.293; <italic>p</italic> = 0.019), whereas the correlation with depression did not yield significance and psychological symptoms were not correlated with GABA+ in HCs. Prefrontal Glx levels showed no association with anxiety or depression in either group. Neurotransmitter concentrations in mPFC did not correlate with any disease-related measure. Exploratory correlational analyses regarding associations of anxiety and depression with tNA, tCr and Cho revealed no significant results (all <italic>p</italic> &gt; 0.242; data not shown). Based on correlational findings suggesting distinct associations between mPFC GABA+ concentrations and anxiety in patients, GABA+ was solely considered for further analyses and we focused on anxiety symptoms in subsequent subgroup analyses with patient subgroups based on HADS anxiety scores, as described below.<fig id="Fig2"><label>Figure 2</label><caption><p>Spearman’s rank correlations of mPFC GABA+ concentrations with (<bold>A</bold>) HADS anxiety scores and (<bold>B</bold>) HADS depression scores in all subjects. Patients with IBS (N = 64) are depicted as blue squares, HCs (N = 32) as red circles.</p></caption><graphic xlink:href="41598_2019_50024_Fig2_HTML" id="d30e574"/></fig></p>
        <sec id="Sec6">
          <title>Definition of IBS subgroups based on anxiety scores</title>
          <p id="Par9">To further elucidate the relationship between anxiety symptoms and prefrontal GABA+ levels, the patient sample was subdivided according to low (IBS −; N = 34) or high (IBS +; N = 30) severity of anxiety symptoms. In addition to more symptoms of anxiety (IBS+: M = 14.00 (12.00–16.00); IBS−: M = 8.00 (6.00–9.25); Fig. <xref rid="Fig3" ref-type="fig">3A</xref>), the IBS+ subgroup revealed more depression symptoms relative to IBS− (IBS+: M = 7.50 (4.00–10.75); IBS−: M = 4.00 (2.00–6.00)) (both <italic>p</italic> &lt; 0.001). Patients with high severity of anxiety symptoms reported higher pain intensity and interference (both <italic>p</italic> &lt; 0.05), whereas IBS symptom severity and symptom-specific anxiety were comparable.<fig id="Fig3"><label>Figure 3</label><caption><p>Group differences in HADS anxiety scores (<bold>A</bold>) and mPFC GABA+ concentrations (<bold>B</bold>) between HCs (N = 32; solid blue), IBS patients with low severity of anxiety symptoms (N = 34; red striped) and patients with high severity of anxiety symptoms (N = 30; solid red). Data are given as median and error bars indicate interquartile ranges. **<italic>p</italic> &lt; 0.01; ***<italic>p</italic> &lt; 0.001.</p></caption><graphic xlink:href="41598_2019_50024_Fig3_HTML" id="d30e609"/></fig></p>
        </sec>
        <sec id="Sec7">
          <title><italic>Subgroup analyses of mPFC</italic> GABA+ <italic>concentrations</italic></title>
          <p id="Par10">Kruskal-Wallis test revealed a significant effect of group on mPFC GABA+ concentrations (<italic>X</italic><sup>2</sup><sub>(2)</sub> = 8.346; <italic>p</italic> = 0.014). Post hoc <italic>U</italic>-tests demonstrated significantly higher GABA+ concentrations in the IBS+ relative to the IBS− subgroup (<italic>U</italic> = 299.50; <italic>p</italic> = 0.004) and to HCs (<italic>U</italic> = 336.50; <italic>p</italic> = 0.045; Fig. <xref rid="Fig3" ref-type="fig">3B</xref>), the latter failing statistical significance after Bonferroni correction. No differences in GABA+ concentrations were observed between IBS− and HCs. On removing data from patients taking antidepressant medication, subgroup analyses yielded similar results (Supplementary Notes <xref rid="MOESM1" ref-type="media">S2b</xref>).</p>
        </sec>
      </sec>
      <sec id="Sec8">
        <title>Analyses of resting-state FC</title>
        <p id="Par11">To determine whether the association between biochemical alterations in mPFC and symptoms of anxiety was paralleled by altered FC, exploratory analyses of connectivity</p>
        <p id="Par12">from mPFC to amygdala, ACC and insula, respectively, were conducted. Patients showed significantly reduced FC between mPFC and ACC (t = 2.36; <italic>p</italic><sub>FDR</sub> = 0.02; Fig. <xref rid="Fig4" ref-type="fig">4A</xref>) and between mPFC and right insula relative to HCs (t = 2.37; <italic>p</italic><sub>FDR</sub> = 0.02; Fig. <xref rid="Fig4" ref-type="fig">4B</xref>), whereas no group differences were observed in mPFC – amygdala FC (data not shown). These group differences were confirmed by analyses on extracted mean FC values (ACC: <italic>U</italic> = 712.00; <italic>p</italic> = 0.018; right insula: <italic>U</italic> = 755.00; <italic>p</italic> = 0.047). Exploratory correlational analyses suggested connectivity between mPFC and ACC to be distinctly related to anxiety in IBS (<italic>r</italic><sub><italic>s</italic></sub> = −0.356; <italic>p</italic> = 0.004), while effects for FC between mPFC and insula or amygdala failed statistical significance. Based on between-group and correlational findings, subgroup analyses focused on mPFC – ACC FC. Kruskal-Wallis test comparing mean FC in IBS+ , IBS−, and HCs revealed a significant effect of group (<italic>X</italic><sup>2</sup><sub>(2)</sub> = 13.71; <italic>p</italic> &lt; 0.001). Post-hoc <italic>U</italic>-tests confirmed reduced mPFC – ACC connectivity in IBS patients with high when compared to the subgroup with low anxiety symptom severity (<italic>U</italic> = 273.00; <italic>p</italic> = 0.002) and to HCs (<italic>U</italic> = 234.00; <italic>p</italic> = 0.001), while IBS− did not differ from HCs (Fig. <xref rid="Fig4" ref-type="fig">4C</xref>).<fig id="Fig4"><label>Figure 4</label><caption><p>Results from group comparisons of resting-state FC between mPFC and ACC (<bold>A</bold>) and between mPFC and insula (<bold>B</bold>) (HCs &gt; IBS). (<bold>C</bold>) Subgroup comparisons of FC in patients with high severity of anxiety symptoms (IBS+; N = 30; solid red), patients with low anxiety symptom severity (IBS−; N = 33; red striped) and HCs (N = 32; solid blue). Data are given as median and error bars indicate interquartile ranges. **<italic>p</italic> &lt; 0.01.</p></caption><graphic xlink:href="41598_2019_50024_Fig4_HTML" id="d30e746"/></fig></p>
      </sec>
      <sec id="Sec9">
        <title>Association between mPFC GABA+, FC and anxiety in patients</title>
        <p id="Par13">Finally, to explore the predictive value of mPFC FC and GABA+ concentrations for anxiety severity in IBS patients, exploratory multiple regression analyses were conducted, entering mPFC – ACC FC and GABA+ as predictors. Analyses revealed both, higher GABA+ (ß = 0.272; t = 2.35; <italic>p</italic> = 0.022) and decreased mPFC - ACC FC (ß = −0.323; t = −2.78; <italic>p</italic> = 0.007) to be independent predictors of anxiety in patients with IBS. The significant model including both measures (F = 6.59; <italic>p</italic> = 0.003) accounted for almost 18% of variance in anxiety severity (R<sup>2</sup> for separate regressors: GABA+ = 0.074; mPFC FC = 0.103).</p>
      </sec>
    </sec>
    <sec id="Sec10" sec-type="discussion">
      <title>Discussion</title>
      <p id="Par14">This multimodal study provides novel evidence of increased GABAergic neurotransmitter levels in mPFC, a core node of inhibitory control with a crucial role in emotion regulation, in women with IBS suffering from high severity of anxiety symptoms. Higher anxiety in patients was further associated with reduced FC between mPFC and adjacent ACC and both, increased GABA+ and reduced connectivity independently predicted higher anxiety symptom severity. These findings suggest that both, a disruption of inhibitory neurotransmission and blunted FC within prefrontal regulatory circuits may be involved in increased severity of anxiety frequently observed in IBS. Importantly, alterations in GABA concentrations were only evident in patients with high, not those with lower severity of anxiety symptoms and were not associated with depression, pain or GI symptoms. Therefore, our data suggest an effect distinctly associated with anxiety rather than the chronic pain condition itself.</p>
      <p id="Par15">Disturbances in GABA-mediated inhibitory control, likely via dysfunctional top-down modulation, are increasingly acknowledged in the pathophysiology of anxiety disorders<sup><xref ref-type="bibr" rid="CR25">25</xref></sup>. Reduced inhibitory modulation appears to be associated with hyper-excitability of limbic regions that mediate emotional responses, conceivably resulting in an exaggerated expression of fear and anxiety<sup><xref ref-type="bibr" rid="CR25">25</xref></sup>. The close relationship between prefrontal GABA, functional coupling within corticolimbic circuits, and anxiety has recently been demonstrated in healthy volunteers<sup><xref ref-type="bibr" rid="CR23">23</xref>,<xref ref-type="bibr" rid="CR24">24</xref></sup>. It is further consistent with hypo-activity in prefrontal regions, paralleled by hyper-activation of subcortical areas associated with the experience and expression of anxiety in posttraumatic stress disorder<sup><xref ref-type="bibr" rid="CR26">26</xref></sup>. Our findings substantially extend this evidence by implicating disturbances in inhibitory neurotransmission as a biochemical underpinning of disturbed emotion processing and regulation and a key mechanism potentially underlying increased comorbidity with anxiety also in IBS. They further provide novel insights into the close relation between frequently reported functional brain alterations and psychological symptoms in IBS patients<sup><xref ref-type="bibr" rid="CR10">10</xref>–<xref ref-type="bibr" rid="CR12">12</xref></sup>. Specifically, in patients with high anxiety symptom severity, we observed decreased mPFC connectivity with ACC, a core node of the limbic system with a unique integrative role in emotion regulation<sup><xref ref-type="bibr" rid="CR27">27</xref>,<xref ref-type="bibr" rid="CR28">28</xref></sup>. These observations complement previous reports of abnormal top-down modulation in IBS and other disorders of brain-gut-communication<sup><xref ref-type="bibr" rid="CR29">29</xref>,<xref ref-type="bibr" rid="CR30">30</xref></sup>. Of note, regression findings suggested these alterations on functional and biochemical levels in patients with IBS to be independent rather than directly linked phenomena. Together, our multimodal findings support a model of excessive GABA-mediated inhibition of mPFC and compromised prefrontal connectivity, which both might contribute to a failure of effectively engaging regulatory processes and to dysfunctional inhibitory control as mechanisms involved in increased anxiety symptom severity in IBS.</p>
      <p id="Par16">While higher mPFC GABA+ concentrations in IBS patients with increased severity of anxiety supported our hypothesis, we did not observe altered Glx levels in patients. Reduced hippocampal excitatory neurotransmitter concentrations have been reported in a single early qMRS study in IBS<sup><xref ref-type="bibr" rid="CR15">15</xref></sup>. A recently published study reporting reduced Glx in bilateral insulae and a hemisphere-specific association with pain and pain coping<sup><xref ref-type="bibr" rid="CR16">16</xref></sup> extends the, to date, scarce evidence in this patient group. Furthermore, evidence of altered glutamatergic neurotransmission involving various brain regions in conditions highly comorbid with IBS such as pelvic pain<sup><xref ref-type="bibr" rid="CR17">17</xref></sup>, fibromyalgia<sup><xref ref-type="bibr" rid="CR18">18</xref></sup>, as well as anxiety disorders<sup><xref ref-type="bibr" rid="CR21">21</xref>,<xref ref-type="bibr" rid="CR31">31</xref></sup> and depression<sup><xref ref-type="bibr" rid="CR20">20</xref></sup> is accumulating. Regarding GABA+, a recent investigation of neurotransmitter levels in women with chronic pelvic pain reported lowered concentrations of GABA+ in ACC of patients, a region adjacent to mPFC. The authors further presented associations of ACC choline, but not GABA+ concentrations, with connectivity to regions of the limbic system and with negative mood<sup><xref ref-type="bibr" rid="CR32">32</xref></sup>. At the same time, work in healthy volunteers specifically targeting mPFC neurotransmission rather supported a distinct association between GABA+, not Glx, and anxiety<sup><xref ref-type="bibr" rid="CR23">23</xref></sup>, consistent with our observations. As recently proposed, these partly inconsistent findings on neurotransmission in the human brain might be attributable to disease-, symptom- as well as region-specific alterations<sup><xref ref-type="bibr" rid="CR33">33</xref></sup>. Supporting this assumption, we did not find associations between mPFC GABA+ and disease-related measures such as GI symptom severity or pain, whereas a previous observation from our laboratory suggested a link between insular Glx with pain and pain coping in IBS, yet no association with emotional factors and no differences in GABA+ between patients and controls<sup><xref ref-type="bibr" rid="CR16">16</xref></sup>. Furthermore, while patients with high severity of anxiety symptoms also exhibited elevated severity of depression, two symptom clusters with large overlap<sup><xref ref-type="bibr" rid="CR34">34</xref></sup>, anxiety but not depression symptoms appeared to be distinctly associated with GABA levels in patients. Our findings might therefore suggest altered prefrontal GABA to be a mechanism specific to anxiety rather than the chronic pain condition or psychological symptoms in general. Such specificity might further explain comparable neurotransmitter levels between female patients in general and healthy women, yet distinct alterations in subgroups based on anxiety symptom severity observed herein, further underscoring IBS heterogeneity<sup><xref ref-type="bibr" rid="CR35">35</xref></sup>.</p>
      <p id="Par17">Finally, despite the observed association between altered inhibitory neurotransmission and anxiety, we did not find an association between symptoms of anxiety and mPFC – amygdala FC in IBS patients. While amygdala is considered a key region of the limbic system with crucial relevance in anxiety disorders<sup><xref ref-type="bibr" rid="CR25">25</xref></sup>, recent evidence supports a broader network including ACC and insula along with prefrontal cortex in the pathophysiology of emotional disturbances<sup><xref ref-type="bibr" rid="CR9">9</xref>,<xref ref-type="bibr" rid="CR26">26</xref></sup>. Functional alterations in ACC and insula are among the most consistently reported brain imaging findings in IBS, whereas a specific role of amygdala remains inconclusive<sup><xref ref-type="bibr" rid="CR7">7</xref>,<xref ref-type="bibr" rid="CR8">8</xref></sup>. Although exploratory in nature, our connectivity findings suggest that alterations in pathways involving mPFC and adjacent ACC, rather than amygdala, might be related to anxiety symptoms in IBS.</p>
      <p id="Par18">This study is not without limitations. We based our subgrouping of patients with high and low anxiety symptom severity on HADS scores. While we applied a conservative cut-off, HADS does not allow a proper psychiatric diagnosis. Future research addressing the association between brain alterations, including biochemical changes, and psychiatric comorbidity in disorders of brain-gut communication should implement diagnostic tools such as semi-structured interviews and clinical judgment<sup><xref ref-type="bibr" rid="CR36">36</xref></sup>. Further, the qMRS protocol applied is optimized for the detection of GABA+. Although the signal-to-noise benefits achieved by a large voxel appeared to provide adequate sensitivity for Glx, we cannot rule out that our findings were affected by the chosen methodological approach. In addition, mPFC and ACC have previously been proposed to possess shared, but also distinct functional properties<sup><xref ref-type="bibr" rid="CR9">9</xref></sup>. This is important not only with respect to spectroscopic findings, but also to connectivity analyses using a custom-built mPFC ROI, which corresponded to the voxel applied in qMRS, yet partly overlapped with the rostral proportion of ACC. Future research is needed, using a smaller voxel size for spectroscopic measures to allow targeting these prefrontal subregions specifically. In the current analysis, data were not adjusted for possibly divergent contributions of grey matter, white matter and cerebrospinal fluid to the voxel under investigation in patients and controls. Based on our previous experience applying quantitative MRI (qMRI) for tissue classification<sup><xref ref-type="bibr" rid="CR37">37</xref></sup>, we decided not to include qMRI in the current protocol. Of note, cortical GABA concentrations are reportedly higher in grey relative to white matter and concentrations are negligible in cerebrospinal fluid<sup><xref ref-type="bibr" rid="CR38">38</xref>,<xref ref-type="bibr" rid="CR39">39</xref></sup>. Evidence from structural brain imaging in IBS supports decreased prefrontal grey matter density in patients<sup><xref ref-type="bibr" rid="CR40">40</xref>,<xref ref-type="bibr" rid="CR41">41</xref></sup>, which would rather suggest a relatively lowered concentration of the inhibitory neurotransmitter in the voxel of interest. While we cannot fully exclude that group differences observed in GABA+ concentrations may have been affected by distinct features in tissue contribution, these previous findings support that increased prefrontal GABA+ in IBS as observed herein, is unlikely to be mainly attributable to differences in tissue contribution between women with IBS and healthy women. Our study protocol did not include measurements of a control region such as the occipital cortex to substantiate the specificity of effects to the PFC observed herein. However, recently published data from our own group addressing insular metabolite concentrations in IBS patients lend support for such specificity<sup><xref ref-type="bibr" rid="CR16">16</xref></sup>. Precisely, the observation of lowered Glx, yet unaltered GABA+ concentrations, in bilateral anterior insulae in patients suggests region-, as well as symptom-specific alterations rather than a general and widespread neurotransmitter dysbalance in IBS in support of GABAergic abundance specific to PFC in patients with high anxiety severity. Regarding the sample under investigation, our findings were derived from women only, limiting generalizability to men with IBS. Given evidence of sex-related differences in brain function in patients with IBS<sup><xref ref-type="bibr" rid="CR42">42</xref></sup>, more research including both women and men is needed, which would also allow the investigation of putative sex-/gender-specific alterations of prefrontal excitatory and inhibitory neurotransmission. Finally, a small proportion of patients were taking antidepressant medication. However, our additional analyses excluding these patients confirmed our findings of increased GABA+ levels in IBS patients with more severe anxiety symptoms. Therefore, it appears unlikely that the observed alterations were primarily attributable to centrally-acting pharmacological agents.</p>
      <sec id="Sec11">
        <title>Conclusions and future directions</title>
        <p id="Par19">Our findings provide first evidence that dysfunctional prefrontal GABAergic neurotransmission and aberrant mPFC – ACC connectivity may form independent biochemical and functional substrates of increased anxiety as a frequent psychiatric comorbidity in IBS. Future multimodal studies including adequate disease control groups, especially patients with anxiety disorders but without gastrointestinal symptoms, could provide further insights into the specificity of and relation between altered prefrontal inhibitory neurotransmission, corticolimbic connectivity, psychological symptoms, and dysfunctional brain-gut communication. This is of particular importance given bidirectional brain-gut interactions to appear of crucial relevance beyond gastrointestinal complaints. Accumulating evidence, primarily from preclinical models, supports a key role of the gut microbiome and its communication pathways in shaping neural mechanisms, including brain biochemistry<sup><xref ref-type="bibr" rid="CR43">43</xref>,<xref ref-type="bibr" rid="CR44">44</xref></sup>, and behavior<sup><xref ref-type="bibr" rid="CR45">45</xref></sup>. Findings suggest a putative role of microbiome-gut-brain pathways also in neuropsychiatric diseases, including anxiety and depression<sup><xref ref-type="bibr" rid="CR46">46</xref></sup>. A recent experimental human model supports a close association between the microbial composition, brain structure and neural processing of emotional stimuli in healthy individuals<sup><xref ref-type="bibr" rid="CR47">47</xref></sup>, extending evidence derived from elegant translational models<sup><xref ref-type="bibr" rid="CR48">48</xref></sup> or correlational approaches<sup><xref ref-type="bibr" rid="CR49">49</xref></sup>. Together with these promising findings, our observations warrant further multimodal research approaches to help shed light on the complex interplay of central and peripheral mechanisms at the interface of neurogastroenterology and psychiatry.</p>
      </sec>
    </sec>
    <sec id="Sec12">
      <title>Methods</title>
      <sec id="Sec13">
        <title>Participants</title>
        <p id="Par20">Based on the high female preponderance in IBS<sup><xref ref-type="bibr" rid="CR50">50</xref></sup> and increased symptoms of anxiety and depression in women<sup><xref ref-type="bibr" rid="CR51">51</xref></sup>, only female participants were included in this study. A total of 73 right-handed women (mean age, 31.73 ± 8.86 years) with a diagnosis of IBS based on Rome III diagnostic criteria were referred to the gastrointestinal unit of the Linköping University Hospital, Sweden, and 38 right-handed female healthy controls (HCs; mean age 33.45 ± 10.99 years) were recruited by local advertisement. Patients underwent a standard clinical examination to exclude organic gastrointestinal diseases and a laboratory examination was performed. Celiac disease was excluded on the basis of transglutaminase antibodies, and inflammatory bowel disease was excluded by f-calprotectin test. Exclusion criteria were metabolic, neurological, or severe psychiatric disorders (e.g., schizophrenia), smoking, claustrophobia, pacemaker, large tattoos, and metal implants. Of note, patients were not encouraged to refrain from antidepressant medication when enrolled in the study. In HCs, a medical history of GI disturbances, psychiatric conditions, or centrally-acting medication were exclusionary. Informed written consent was obtained from all participants and the study was approved by the Regional Research Committee for Ethical Issues at the Faculty of Health Sciences, Linköping, Sweden (Number: 2013/111-31) and conducted in accordance with the Declaration of Helsinki.</p>
      </sec>
      <sec id="Sec14">
        <title>Questionnaires</title>
        <p id="Par21">Prior to the study day, all participants completed the following questionnaires for the assessment of anxiety and depression symptom severity and of disease-related measures in their home environment. This approach was chosen to exclude possibly confounding effects induced by the scanner setting, such as an increase in distress<sup><xref ref-type="bibr" rid="CR52">52</xref></sup> with a putative impact on measures of anxiety and depression symptom severity.</p>
      </sec>
      <sec id="Sec15">
        <title>Hospital Anxiety and Depression Scale (HADS)</title>
        <p id="Par22">The Hospital Anxiety and Depression Scale (HADS) was used to assess symptoms of anxiety and depression<sup><xref ref-type="bibr" rid="CR53">53</xref></sup>. The self-assessment questionnaire consists of 7 items per subscale scored on a 4-point scale, with each sum score ranging from 0 to 21. Cut-off scores are defined as ≥8 for suspicious and ≥11 for definite cases of anxiety and depression, respectively<sup><xref ref-type="bibr" rid="CR34">34</xref>,<xref ref-type="bibr" rid="CR53">53</xref></sup>.</p>
      </sec>
      <sec id="Sec16">
        <title>Visceral Sensitivity Index (VSI)</title>
        <p id="Par23">The Visceral Sensitivity Index (VSI) was implemented to measure GI symptom-specific anxiety<sup><xref ref-type="bibr" rid="CR54">54</xref></sup>. This 15-item self-report questionnaire assesses cognitive, emotional, and behavioural responses to fear of GI symptoms. Sum scores range from 0 to 75 with higher scores indicating more severe symptom-specific anxiety.</p>
      </sec>
      <sec id="Sec17">
        <title>IBS Severity Scoring System (IBS-SSS)</title>
        <p id="Par24">The IBS Severity Scoring System (IBS-SSS) was used to evaluate the severity of abdominal pain, distension, stool frequency and consistency, and interference with life<sup><xref ref-type="bibr" rid="CR55">55</xref></sup>. Sum scores ranging from 0 to 500 indicate mild (75–175), moderate (175–300), or severe (&gt;300) IBS.</p>
      </sec>
      <sec id="Sec18">
        <title>Brief Pain Inventory (BPI)</title>
        <p id="Par25">The Brief Pain Inventory (BPI) was implemented to assess pain intensity and interference with functional and emotional domains<sup><xref ref-type="bibr" rid="CR56">56</xref></sup>. Sum scores range from 0 to 40 and 0 to 70 for pain intensity and interference, respectively, with higher scores indicating higher levels of intensity and interference.</p>
      </sec>
      <sec id="Sec19">
        <title>MR data acquisition and analyses</title>
        <p id="Par26">Participants were instructed to refrain from consuming alcohol and using sleep or pain medication for at least 24 hours and to fast for at least four hours before MR data acquisition. All MR measurements were conducted using a 32-channel head coil on a 3 T Philips Ingenia MR-system (Philips Healthcare, Best, Netherlands). An initial structural brain scan was acquired to exclude brain abnormalities and allow accurate voxel placement for subsequent spectroscopy measures based on individual T<sub>1</sub>-weighted images.</p>
        <p id="Par27">Following structural MRI, qMRS data were acquired using a MEGA-PRESS pulse sequence<sup><xref ref-type="bibr" rid="CR57">57</xref>,<xref ref-type="bibr" rid="CR58">58</xref></sup> with the following parameters: TR/TE = 2000/68 ms, edited pulses ON at 1.90ppm and OFF at 7.46ppm, water suppression MOIST, 40 dynamics with a voxel of 30 × 30 × 30 mm<sup>3</sup> placed in the mPFC (Fig. <xref rid="Fig5" ref-type="fig">5A</xref>). Subsequently, a 2-dynamic unsuppressed water reference measurement was collected to obtain a reference of water in the tissue within the voxel used, for the purpose of water scaling and phasing. Data were individually (<italic>i</italic>.<italic>e</italic>., data from each time point) phase-corrected<sup><xref ref-type="bibr" rid="CR59">59</xref></sup> and frequency-aligned based on the water residual in the water-suppressed data. A difference spectrum was computed by subtracting the average OFF-spectrum (Fig. <xref rid="Fig5" ref-type="fig">5B</xref>) from the average ON-spectrum and used as input to LCModel<sup><xref ref-type="bibr" rid="CR60">60</xref></sup> (Version 6.3-1L) to compute GABA+ concentrations<sup><xref ref-type="bibr" rid="CR61">61</xref></sup> (Fig. <xref rid="Fig5" ref-type="fig">5C</xref>). Analysis of OFF-spectrum dynamics was used to assess concentrations of Glx (Glu + Gln)<sup><xref ref-type="bibr" rid="CR62">62</xref></sup>. The combined measure Glx rather than Glu and Gln separately was assessed based on the similar molecular structure of these metabolites, resulting in spectra with substantial overlap due to scalar couplings. At the field strength applied and with a protocol optimized for the detection of GABA+, a reliable distinction of Glu and Gln spectra is challenging<sup><xref ref-type="bibr" rid="CR63">63</xref></sup>, limiting the interpretation of findings on these metabolites separately. Therefore, concentrations of Glx representing the entire pool of Glu and Gln in the voxel under investigation are reported.<fig id="Fig5"><label>Figure 5</label><caption><p>Typical qMRS volume of interest (voxel size 3 × 3 × 3 cm<sup>3</sup>) placement in the mPFC (<bold>A</bold>), representative spectra with LCModel fitting, depicting an averaged MEGA-PRESS OFF spectrum for Glx extraction (labeled as 2 and 7, extracted solely from OFF-spectra (<bold>B</bold>)) and a difference spectrum for the extraction of GABA+ (<bold>C</bold>) from a healthy volunteer (gray line: post-processed spectra prior to fitting; red line: LCModel fit). Residuals are shown at the top of each panel. Assignments: 1, Creatine (-<sup>2</sup>CH<sub>2</sub>-); 2, Glx (-<sup>2</sup>CH-); 3, Choline (-N(CH<sub>3</sub>)<sub>3</sub>); 4, Creatine (-N(CH<sub>3</sub>)); 5, GABA+ (-<sup>4</sup>CH<sub>2</sub>-); 6, tNA (-<sup>3</sup>CH<sub>2</sub>-); 7, Glx (-<sup>4</sup>CH<sub>2</sub>-); 8, GABA+ (-<sup>2</sup>CH<sub>2</sub>-); 9, tNA (-<sup>2</sup>CH<sub>3</sub>); 10. GABA+ (-<sup>3</sup>CH<sub>2</sub>-); 11–13, Macromolecules and lipids, -CH<sub>2</sub>-)<sup><xref ref-type="bibr" rid="CR62">62</xref></sup>. Abbreviations: Glx, glutamate + glutamine; GABA+, γ-Aminobutyric acid (+macromolecule signal); tNA, total N-acetylaspartate (NAA + NAAG).</p></caption><graphic xlink:href="41598_2019_50024_Fig5_HTML" id="d30e1167"/></fig></p>
        <p id="Par28">In addition to the primary outcome parameters GABA+ and Glx, concentrations of total N-acetylaspartate (tNAA), Creatine (tCr) and Choline (Cho) as putative markers of neuronal health<sup><xref ref-type="bibr" rid="CR64">64</xref></sup> and neuro-inflammation<sup><xref ref-type="bibr" rid="CR65">65</xref>,<xref ref-type="bibr" rid="CR66">66</xref></sup> were extracted from OFF spectra for exploratory between-group comparisons and correlational analyses. Data were analysed with LCModel (v.6.3-1L) using the most current basis sets from the laboratory of Dydak <italic>et al</italic>.<sup><xref ref-type="bibr" rid="CR67">67</xref></sup> with the following parameters: SPTYPE = mega-press-3, PPMST = 4.2, PPMEND = 1.95, DOWS = T, otherwise default values. All concentrations were water-scaled using the water reference, resulting in concentrations with absolute units of mM. Concentrations were not adjusted for contributions of grey matter, white matter and cerebrospinal fluid in the voxel of interest.</p>
        <p id="Par29">Spectra were quality controlled based on linewidth and data with a full-width half-maximun (FWHM) above 0.1 ppm were discarded (5 IBS, 4 HCs). In addition, each spectrum was visually inspected and datasets were excluded when lipid contamination obscuring other signals in the spectra was detected (4 IBS, 2 HCs), resulting in a final sample of N = 64 IBS patients (mean age, 31.55 ± 8.77 years) and N = 32 HCs (mean age 34.16 ± 10.72 years) for statistical analyses. For all included datasets, estimated relative standard deviations (Cramér-Rao lower bounds, CRLB) were &lt;10% SD for GABA+ and for Glx, respectively.</p>
        <p id="Par30">Subsequent to spectroscopic measures, ten-minute eyes-closed resting-state fMRI data were acquired using a single-shot gradient-echo echo-planar imaging sequence with the following parameters: TR/TE = 2000/37 ms, voxel size 3.59 × 3.59 × 4.00 mm<sup>3</sup>, 28 slices and SENSE factor 2.00, which effectively covered the entire brain. Data were reconstructed on the scanner and preprocessed using SPM8 (Wellcome Trust Centre for Neuroimaging, UCL, London, UK) implemented in MATLAB R2015b (MathWorks, Natick, MA, USA). Images were realigned using the INRIalign toolbox<sup><xref ref-type="bibr" rid="CR68">68</xref>,<xref ref-type="bibr" rid="CR69">69</xref></sup>, and translation and rotation parameters were examined to exclude head motion exceeding one voxel in any direction. Functional images were spatially normalized into standardized Montreal Neurological Institute (MNI) space and smoothed with an 8 mm FWHM Gaussian kernel.</p>
        <p id="Par31">FC analysis was carried out in the CONN functional connectivity v17b toolbox<sup><xref ref-type="bibr" rid="CR70">70</xref></sup>; (<ext-link ext-link-type="uri" xlink:href="http://www.nitrc.org/projects/conn">http://www.nitrc.org/projects/conn</ext-link>) on 95 of the 96 subjects, as one IBS patient was missing fMRI data. Data were submitted to the CONN standard denoising step, including band-pass filtering (0.008–0.09 Hz) and linear detrending. Motion regressors were included for all subjects. For first-level statistical analysis, a bivariate correlation using a weighted general linear model and hemodynamic response function weighting was conducted. Three separate ROI-to-ROI (region of interest) analyses were performed from a custom-built mPFC cubic voxel, designed to correspond to the qMRS voxel regarding size and approximate location, to bilateral amygdala, insula, and ACC, respectively. ROIs for amygdala, insula and ACC were selected from the Harvard-Oxford parcellated grey-matter atlas<sup><xref ref-type="bibr" rid="CR71">71</xref>–<xref ref-type="bibr" rid="CR74">74</xref></sup>. For these exploratory ROI-to-ROI analyses, significance was taken at <italic>p</italic> &lt; 0.05 using FDR correction. Post-hoc results were considered significant at <italic>p</italic> &lt; 0.05.</p>
      </sec>
      <sec id="Sec20">
        <title>Statistical analyses</title>
        <p id="Par32">Statistical analyses were performed using the IBM SPSS Statistics 25 software (IBM Corporation, Armonk, NY, USA). Shapiro-Wilk test revealed non-normal distribution of questionnaire data in HCs. Therefore, non-parametric tests were applied with Mann-Whitney <italic>U</italic>-test to assess differences between IBS patients and HCs and Spearman’s Rho for correlational analyses. To further elucidate the relation between neurotransmitter concentrations and psychological symptom severity in IBS, patient subgroups were defined based on HADS scores ≥11 as a well-established cut-off for the detection of anxiety or depression caseness<sup><xref ref-type="bibr" rid="CR34">34</xref>,<xref ref-type="bibr" rid="CR53">53</xref></sup>. Between-group analyses were performed using Kruskal-Wallis test followed by post-hoc <italic>U</italic>-tests with Bonferroni correction. Mean FC values from CONN ROI-to-ROI analyses were extracted and entered into exploratory group, subgroup, and correlational analyses. Finally, multiple regression analyses with neurotransmitter and FC data entered as predictor variables were conducted in patients to further explore the link between neurotransmission, resting state connectivity and psychological symptom severity. Alpha-levels for statistical tests were set at <italic>p</italic> &lt; 0.05. Exact two-tailed <italic>p</italic> values are provided, using the Monte Carlo method for group comparisons, and applying bootstrapping for correlational analyses, both with 10.000 iterations and a confidence level of 99%. Results from group comparisons are reported as median and interquartile range (IQR).</p>
        <p id="Par33">The datasets generated and analysed during the current study are available from the corresponding author on reasonable request.</p>
      </sec>
    </sec>
    <sec sec-type="supplementary-material">
      <title>Supplementary information</title>
      <sec id="Sec21">
        <p>
<supplementary-material content-type="local-data" id="MOESM1"><media xlink:href="41598_2019_50024_MOESM1_ESM.pdf"><caption><p>Elucidating the putative link between prefrontal neurotransmission, functional connectivity, and affective symptoms in irritable bowel syndrome: Supplementary information</p></caption></media></supplementary-material>
</p>
      </sec>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn>
        <p><bold>Publisher’s note</bold> Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
      </fn>
    </fn-group>
    <sec>
      <title>Supplementary information</title>
      <p><bold>Supplementary information</bold> accompanies this paper at 10.1038/s41598-019-50024-3.</p>
    </sec>
    <ack>
      <title>Acknowledgements</title>
      <p>We thank Richard Edden of Johns Hopkins in Baltimore for very generously providing the MEGA-PRESS pulse sequence and other tools developed under NIH GRANTS P41 015909 and R01 016089. We are further very grateful to the following for providing the segmentations used to create the fMRI atlases: David Kennedy and Christian Haselgrove, Centre for Morphometric Analysis, Harvard; Bruce Fischl, the Martinos Center for Biomedical Imaging, MGH (NIH grants P41-RR14075, R01 RR16594-01A1, R01 NS052585-01); Janis Breeze and Jean Frazier from the Child and Adolescent Neuropsychiatric Research Program, Cambridge Health Alliance (NIH grants K08 MH01573, K01 MH01798); Larry Seidman and Jill Goldstein from the Department of Psychiatry of Harvard Medical School. We would also like to thank Prof. Maria Engström for excellent scientific support. This work was supported by the County Council of Östergötland, the AFA research foundation, the Bengt-Ihre fund and the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) – IC 81/1-1 and project number 316803389 – SFB 1280. This study was also supported by Kurt and Helena Widéns Research Fund, and the ‘Seeing Organ Function’ project funded by the Knut and Alice Wallenberg Foundation. The funding agencies had no role in the conception, analysis, or interpretation of the data. Open access funding provided by Linköping University.</p>
    </ack>
    <notes notes-type="author-contribution">
      <title>Author Contributions</title>
      <p>A.I., S.T., O.B. and S.T.W. acquired the data. A.I., S.T., O.B., S.T.W., A.T., P.L. and S.E. analysed the data. A.T., P.L. and S.W. designed the study. S.W. acquired funding. A.I., S.E. and S.W. drafted the manuscript. All authors contributed to the interpretation of data, critical revision of the manuscript for important intellectual content and approved the final version of the manuscript.</p>
    </notes>
    <notes id="FPar1" notes-type="COI-statement">
      <title>Competing Interests</title>
      <p id="Par34">The authors declare no competing interests.</p>
    </notes>
    <ref-list id="Bib1">
      <title>References</title>
      <ref id="CR1">
        <label>1.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Al Omran</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Aziz</surname>
              <given-names>Q</given-names>
            </name>
          </person-group>
          <article-title>The brain-gut axis in health and disease</article-title>
          <source>Adv. Exp. Med. Biol.</source>
          <year>2014</year>
          <volume>817</volume>
          <fpage>135</fpage>
          <lpage>153</lpage>
          <pub-id pub-id-type="pmid">24997032</pub-id>
        </element-citation>
      </ref>
      <ref id="CR2">
        <label>2.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Whitehead</surname>
              <given-names>WE</given-names>
            </name>
            <name>
              <surname>Palsson</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Jones</surname>
              <given-names>KR</given-names>
            </name>
          </person-group>
          <article-title>Systematic review of the comorbidity of irritable bowel syndrome with other disorders: what are the causes and implications?</article-title>
          <source>Gastroenterology</source>
          <year>2002</year>
          <volume>122</volume>
          <fpage>1140</fpage>
          <lpage>1156</lpage>
          <pub-id pub-id-type="pmid">11910364</pub-id>
        </element-citation>
      </ref>
      <ref id="CR3">
        <label>3.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fond</surname>
              <given-names>G</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Anxiety and depression comorbidities in irritable bowel syndrome (IBS): a systematic review and meta-analysis</article-title>
          <source>Eur. Arch. Psychiatry Clin. Neurosci.</source>
          <year>2014</year>
          <volume>264</volume>
          <fpage>651</fpage>
          <lpage>660</lpage>
          <pub-id pub-id-type="pmid">24705634</pub-id>
        </element-citation>
      </ref>
      <ref id="CR4">
        <label>4.</label>
        <mixed-citation publication-type="other">Drossman, D. A. <italic>et al</italic>. Severity in irritable bowel syndrome: a Rome Foundation Working Team report. <italic>Am</italic>. <italic>J</italic>. <italic>Gastroenterol</italic>. <bold>106</bold>, 1749–59, quiz 1760 (2011).</mixed-citation>
      </ref>
      <ref id="CR5">
        <label>5.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Koloski</surname>
              <given-names>NA</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The brain-gut pathway in functional gastrointestinal disorders is bidirectional: a 12-year prospective population-based study</article-title>
          <source>Gut</source>
          <year>2012</year>
          <volume>61</volume>
          <fpage>1284</fpage>
          <lpage>1290</lpage>
          <pub-id pub-id-type="pmid">22234979</pub-id>
        </element-citation>
      </ref>
      <ref id="CR6">
        <label>6.</label>
        <mixed-citation publication-type="other">Jones, M. P. <italic>et al</italic>. Mood and Anxiety Disorders Precede Development of Functional Gastrointestinal Disorders in Patients but not in the Population. <italic>Clin</italic>. <italic>Gastroenterol</italic>. <italic>Hepatol</italic>., 10.1016/j.cgh.2016.12.032 (2017).</mixed-citation>
      </ref>
      <ref id="CR7">
        <label>7.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mayer</surname>
              <given-names>EA</given-names>
            </name>
            <name>
              <surname>Gupta</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Kilpatrick</surname>
              <given-names>LA</given-names>
            </name>
            <name>
              <surname>Hong</surname>
              <given-names>J-Y</given-names>
            </name>
          </person-group>
          <article-title>Imaging brain mechanisms in chronic visceral pain</article-title>
          <source>Pain</source>
          <year>2015</year>
          <volume>156</volume>
          <fpage>S50</fpage>
          <lpage>S63</lpage>
          <pub-id pub-id-type="pmid">25789437</pub-id>
        </element-citation>
      </ref>
      <ref id="CR8">
        <label>8.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tillisch</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Mayer</surname>
              <given-names>EA</given-names>
            </name>
            <name>
              <surname>Labus</surname>
              <given-names>JS</given-names>
            </name>
          </person-group>
          <article-title>Quantitative meta-analysis identifies brain regions activated during rectal distension in irritable bowel syndrome</article-title>
          <source>Gastroenterology</source>
          <year>2011</year>
          <volume>140</volume>
          <fpage>91</fpage>
          <lpage>100</lpage>
          <pub-id pub-id-type="pmid">20696168</pub-id>
        </element-citation>
      </ref>
      <ref id="CR9">
        <label>9.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Etkin</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Egner</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Kalisch</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Emotional processing in anterior cingulate and medial prefrontal cortex</article-title>
          <source>Trends Cogn. Sci.</source>
          <year>2011</year>
          <volume>15</volume>
          <fpage>85</fpage>
          <lpage>93</lpage>
          <pub-id pub-id-type="pmid">21167765</pub-id>
        </element-citation>
      </ref>
      <ref id="CR10">
        <label>10.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Icenhour</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Neural circuitry of abdominal pain-related fear learning and reinstatement in irritable bowel syndrome</article-title>
          <source>Neurogastroenterol. Motil.</source>
          <year>2015</year>
          <volume>27</volume>
          <fpage>114</fpage>
          <lpage>127</lpage>
          <pub-id pub-id-type="pmid">25557224</pub-id>
        </element-citation>
      </ref>
      <ref id="CR11">
        <label>11.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Elsenbruch</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Affective disturbances modulate the neural processing of visceral pain stimuli in irritable bowel syndrome: an fMRI study</article-title>
          <source>Gut</source>
          <year>2010</year>
          <volume>59</volume>
          <fpage>489</fpage>
          <lpage>495</lpage>
          <pub-id pub-id-type="pmid">19651629</pub-id>
        </element-citation>
      </ref>
      <ref id="CR12">
        <label>12.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Qi</surname>
              <given-names>R</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Intrinsic brain abnormalities in irritable bowel syndrome and effect of anxiety and depression</article-title>
          <source>Brain Imaging Behav.</source>
          <year>2016</year>
          <volume>10</volume>
          <fpage>1127</fpage>
          <lpage>1134</lpage>
          <pub-id pub-id-type="pmid">26556814</pub-id>
        </element-citation>
      </ref>
      <ref id="CR13">
        <label>13.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Harris</surname>
              <given-names>RE</given-names>
            </name>
            <name>
              <surname>Clauw</surname>
              <given-names>DJ</given-names>
            </name>
          </person-group>
          <article-title>Imaging central neurochemical alterations in chronic pain with proton magnetic resonance spectroscopy</article-title>
          <source>Neurosci. Lett.</source>
          <year>2012</year>
          <volume>520</volume>
          <fpage>192</fpage>
          <lpage>196</lpage>
          <pub-id pub-id-type="pmid">22445845</pub-id>
        </element-citation>
      </ref>
      <ref id="CR14">
        <label>14.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mullins</surname>
              <given-names>PG</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Current practice in the use of MEGA-PRESS spectroscopy for the detection of GABA</article-title>
          <source>Neuroimage</source>
          <year>2014</year>
          <volume>86</volume>
          <fpage>43</fpage>
          <lpage>52</lpage>
          <pub-id pub-id-type="pmid">23246994</pub-id>
        </element-citation>
      </ref>
      <ref id="CR15">
        <label>15.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Niddam</surname>
              <given-names>DM</given-names>
            </name>
            <name>
              <surname>Tsai</surname>
              <given-names>S-Y</given-names>
            </name>
            <name>
              <surname>Lu</surname>
              <given-names>C-L</given-names>
            </name>
            <name>
              <surname>Ko</surname>
              <given-names>C-W</given-names>
            </name>
            <name>
              <surname>Hsieh</surname>
              <given-names>J-C</given-names>
            </name>
          </person-group>
          <article-title>Reduced hippocampal glutamate-glutamine levels in irritable bowel syndrome: preliminary findings using magnetic resonance spectroscopy</article-title>
          <source>Am. J. Gastroenterol.</source>
          <year>2011</year>
          <volume>106</volume>
          <fpage>1503</fpage>
          <lpage>1511</lpage>
          <pub-id pub-id-type="pmid">21502999</pub-id>
        </element-citation>
      </ref>
      <ref id="CR16">
        <label>16.</label>
        <mixed-citation publication-type="other">Bednarska, O. <italic>et al</italic>. Reduced excitatory neurotransmitter levels in anterior insulae are associated with abdominal pain in irritable bowel syndrome. <italic>Pain</italic>, 10.1097/j.pain.0000000000001589 (2019).</mixed-citation>
      </ref>
      <ref id="CR17">
        <label>17.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>As-Sanie</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Functional Connectivity Is Associated with Altered Brain Chemistry in Women with Endometriosis-Associated Chronic Pelvic Pain</article-title>
          <source>J. Pain</source>
          <year>2016</year>
          <volume>17</volume>
          <fpage>1</fpage>
          <lpage>13</lpage>
          <pub-id pub-id-type="pmid">26456676</pub-id>
        </element-citation>
      </ref>
      <ref id="CR18">
        <label>18.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Valdés</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Increased glutamate/glutamine compounds in the brains of patients with fibromyalgia: A magnetic resonance spectroscopy study</article-title>
          <source>Arthritis Rheum.</source>
          <year>2010</year>
          <volume>62</volume>
          <fpage>1829</fpage>
          <lpage>1836</lpage>
          <pub-id pub-id-type="pmid">20191578</pub-id>
        </element-citation>
      </ref>
      <ref id="CR19">
        <label>19.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Grachev</surname>
              <given-names>ID</given-names>
            </name>
            <name>
              <surname>Fredrickson</surname>
              <given-names>BE</given-names>
            </name>
            <name>
              <surname>Apkarian</surname>
              <given-names>AV</given-names>
            </name>
          </person-group>
          <article-title>Brain chemistry reflects dual states of pain and anxiety in chronic low back pain</article-title>
          <source>J. Neural Transm.</source>
          <year>2002</year>
          <volume>109</volume>
          <fpage>1309</fpage>
          <lpage>1334</lpage>
          <pub-id pub-id-type="pmid">12373563</pub-id>
        </element-citation>
      </ref>
      <ref id="CR20">
        <label>20.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Haroon</surname>
              <given-names>E</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Conceptual convergence: increased inflammation is associated with increased basal ganglia glutamate in patients with major depression</article-title>
          <source>Mol. Psychiatry</source>
          <year>2016</year>
          <volume>21</volume>
          <fpage>1351</fpage>
          <lpage>1357</lpage>
          <pub-id pub-id-type="pmid">26754953</pub-id>
        </element-citation>
      </ref>
      <ref id="CR21">
        <label>21.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Michels</surname>
              <given-names>L</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Prefrontal GABA and glutathione imbalance in posttraumatic stress disorder: Preliminary findings</article-title>
          <source>Psychiatry Res. - Neuroimaging</source>
          <year>2014</year>
          <volume>224</volume>
          <fpage>288</fpage>
          <lpage>295</lpage>
        </element-citation>
      </ref>
      <ref id="CR22">
        <label>22.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Deligiannidis</surname>
              <given-names>KM</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Resting-state functional connectivity, cortical GABA, and neuroactive steroids in peripartum and peripartum depressed women: a functional magnetic imaging and resonance study</article-title>
          <source>Neuropsychopharmacology</source>
          <year>2018</year>
          <volume>44</volume>
          <fpage>546</fpage>
          <lpage>554</lpage>
          <pub-id pub-id-type="pmid">30327498</pub-id>
        </element-citation>
      </ref>
      <ref id="CR23">
        <label>23.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Delli Pizzi</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>GABA content within the ventromedial prefrontal cortex is related to trait anxiety</article-title>
          <source>Soc. Cogn. Affect. Neurosci.</source>
          <year>2016</year>
          <volume>11</volume>
          <fpage>758</fpage>
          <lpage>766</lpage>
          <pub-id pub-id-type="pmid">26722018</pub-id>
        </element-citation>
      </ref>
      <ref id="CR24">
        <label>24.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Delli Pizzi</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Functional and neurochemical interactions within the amygdala– medial prefrontal cortex circuit and their relevance to emotional processing</article-title>
          <source>Brain Struct. Funct.</source>
          <year>2017</year>
          <volume>222</volume>
          <fpage>1267</fpage>
          <lpage>1279</lpage>
          <pub-id pub-id-type="pmid">27566606</pub-id>
        </element-citation>
      </ref>
      <ref id="CR25">
        <label>25.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nuss</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Anxiety disorders and GABA neurotransmission: A disturbance of modulation</article-title>
          <source>Neuropsychiatr. Dis. Treat.</source>
          <year>2015</year>
          <volume>11</volume>
          <fpage>165</fpage>
          <lpage>175</lpage>
          <pub-id pub-id-type="pmid">25653526</pub-id>
        </element-citation>
      </ref>
      <ref id="CR26">
        <label>26.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Etkin</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Wager</surname>
              <given-names>TD</given-names>
            </name>
          </person-group>
          <article-title>Functional Neuroimaging of Anxiety: A Meta-Analysis of Emotional Processing in PTSD, Social Anxiety Disorder, and Specific Phobia</article-title>
          <source>Am. J. Psychiatry</source>
          <year>2007</year>
          <volume>164</volume>
          <fpage>1476</fpage>
          <lpage>1488</lpage>
          <pub-id pub-id-type="pmid">17898336</pub-id>
        </element-citation>
      </ref>
      <ref id="CR27">
        <label>27.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bush</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Luu</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Posner</surname>
              <given-names>MI</given-names>
            </name>
          </person-group>
          <article-title>Cognitive and emotional influences in anterior cingulate cortex</article-title>
          <source>Trends Cogn. Sci.</source>
          <year>2016</year>
          <volume>4</volume>
          <fpage>215</fpage>
          <lpage>222</lpage>
        </element-citation>
      </ref>
      <ref id="CR28">
        <label>28.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Stevens</surname>
              <given-names>FL</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Anterior Cingulate Cortex: Unique Role in Cognition and Emotion</article-title>
          <source>J. Neuropsychiatry Clin. Neurosci.</source>
          <year>2011</year>
          <volume>23</volume>
          <fpage>121</fpage>
          <lpage>125</lpage>
          <pub-id pub-id-type="pmid">21677237</pub-id>
        </element-citation>
      </ref>
      <ref id="CR29">
        <label>29.</label>
        <mixed-citation publication-type="other">Wilder-Smith, C. H. The balancing act: endogenous modulation of pain in functional gastrointestinal disorders. <italic>Gut</italic><bold>60</bold>, 1589 LP – 1599 (2011).</mixed-citation>
      </ref>
      <ref id="CR30">
        <label>30.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Berman</surname>
              <given-names>SM</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Reduced brainstem inhibition during anticipated pelvic visceral pain correlates with enhanced brain response to the visceral stimulus in women with irritable bowel syndrome</article-title>
          <source>J. Neurosci.</source>
          <year>2008</year>
          <volume>28</volume>
          <fpage>349</fpage>
          <lpage>359</lpage>
          <pub-id pub-id-type="pmid">18184777</pub-id>
        </element-citation>
      </ref>
      <ref id="CR31">
        <label>31.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Amiel</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Mathew</surname>
              <given-names>SJ</given-names>
            </name>
          </person-group>
          <article-title>Glutamate and anxiety disorders</article-title>
          <source>Curr. Psychiatry Rep.</source>
          <year>2007</year>
          <volume>9</volume>
          <fpage>278</fpage>
          <lpage>283</lpage>
          <pub-id pub-id-type="pmid">17880858</pub-id>
        </element-citation>
      </ref>
      <ref id="CR32">
        <label>32.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Harper</surname>
              <given-names>DE</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Relationships between brain metabolite levels, functional connectivity, and negative mood in urologic chronic pelvic pain syndrome patients compared to controls: A MAPP research network study</article-title>
          <source>NeuroImage. Clin.</source>
          <year>2018</year>
          <volume>17</volume>
          <fpage>570</fpage>
          <lpage>578</lpage>
          <pub-id pub-id-type="pmid">29201643</pub-id>
        </element-citation>
      </ref>
      <ref id="CR33">
        <label>33.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Grachev</surname>
              <given-names>ID</given-names>
            </name>
            <name>
              <surname>Apkarian</surname>
              <given-names>AV</given-names>
            </name>
          </person-group>
          <article-title>Chemical Heterogeneity of the Living Human Brain: A Proton MR Spectroscopy Study on the Effects of Sex, Age, and Brain Region</article-title>
          <source>Neuroimage</source>
          <year>2000</year>
          <volume>11</volume>
          <fpage>554</fpage>
          <lpage>563</lpage>
          <pub-id pub-id-type="pmid">10806041</pub-id>
        </element-citation>
      </ref>
      <ref id="CR34">
        <label>34.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bjelland</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Dahl</surname>
              <given-names>AA</given-names>
            </name>
            <name>
              <surname>Haug</surname>
              <given-names>TT</given-names>
            </name>
            <name>
              <surname>Neckelmann</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>The validity of the Hospital Anxiety and Depression Scale</article-title>
          <source>J. Psychosom. Res.</source>
          <year>2002</year>
          <volume>52</volume>
          <fpage>69</fpage>
          <lpage>77</lpage>
          <pub-id pub-id-type="pmid">11832252</pub-id>
        </element-citation>
      </ref>
      <ref id="CR35">
        <label>35.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Holtmann</surname>
              <given-names>GJ</given-names>
            </name>
            <name>
              <surname>Ford</surname>
              <given-names>AC</given-names>
            </name>
            <name>
              <surname>Talley</surname>
              <given-names>NJ</given-names>
            </name>
          </person-group>
          <article-title>Pathophysiology of irritable bowel syndrome. <italic>lancet</italic></article-title>
          <source>Gastroenterol. Hepatol.</source>
          <year>2016</year>
          <volume>1</volume>
          <fpage>133</fpage>
          <lpage>146</lpage>
        </element-citation>
      </ref>
      <ref id="CR36">
        <label>36.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Van Oudenhove</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Aziz</surname>
              <given-names>Q</given-names>
            </name>
          </person-group>
          <article-title>The role of psychosocial factors and psychiatric disorders in functional dyspepsia</article-title>
          <source>Nat. Rev. Gastroenterol. Hepatol.</source>
          <year>2013</year>
          <volume>10</volume>
          <fpage>158</fpage>
          <lpage>167</lpage>
          <pub-id pub-id-type="pmid">23358396</pub-id>
        </element-citation>
      </ref>
      <ref id="CR37">
        <label>37.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tisell</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Leinhard</surname>
              <given-names>OD</given-names>
            </name>
            <name>
              <surname>Warntjes</surname>
              <given-names>JBM</given-names>
            </name>
            <name>
              <surname>Lundberg</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Procedure for quantitative 1H magnetic resonance spectroscopy and tissue characterization of human brain tissue based on the use of quantitative magnetic resonance imaging</article-title>
          <source>Magn. Reson. Med.</source>
          <year>2013</year>
          <volume>70</volume>
          <fpage>905</fpage>
          <lpage>915</lpage>
          <pub-id pub-id-type="pmid">23169203</pub-id>
        </element-citation>
      </ref>
      <ref id="CR38">
        <label>38.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jensen</surname>
              <given-names>JE</given-names>
            </name>
            <name>
              <surname>Frederick</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>de</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Renshaw</surname>
              <given-names>PF</given-names>
            </name>
          </person-group>
          <article-title>Grey and white matter GABA level differences in the human brain using two-dimensional, J-resolved spectroscopic imaging</article-title>
          <source>NMR Biomed.</source>
          <year>2005</year>
          <volume>18</volume>
          <fpage>570</fpage>
          <lpage>576</lpage>
          <pub-id pub-id-type="pmid">16273508</pub-id>
        </element-citation>
      </ref>
      <ref id="CR39">
        <label>39.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Harris</surname>
              <given-names>AD</given-names>
            </name>
            <name>
              <surname>Puts</surname>
              <given-names>NAJ</given-names>
            </name>
            <name>
              <surname>Edden</surname>
              <given-names>RAE</given-names>
            </name>
          </person-group>
          <article-title>Tissue correction for GABA-edited MRS: Considerations of voxel composition, tissue segmentation, and tissue relaxations</article-title>
          <source>J. Magn. Reson. Imaging</source>
          <year>2015</year>
          <volume>42</volume>
          <fpage>1431</fpage>
          <lpage>1440</lpage>
          <pub-id pub-id-type="pmid">26172043</pub-id>
        </element-citation>
      </ref>
      <ref id="CR40">
        <label>40.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Seminowicz</surname>
              <given-names>DA</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Regional Gray Matter Density Changes in Brains of Patients With Irritable Bowel Syndrome</article-title>
          <source>Gastroenterology</source>
          <year>2010</year>
          <volume>139</volume>
          <fpage>48</fpage>
          <lpage>57.e2</lpage>
          <pub-id pub-id-type="pmid">20347816</pub-id>
        </element-citation>
      </ref>
      <ref id="CR41">
        <label>41.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Blankstein</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Diamant</surname>
              <given-names>NE</given-names>
            </name>
            <name>
              <surname>Davis</surname>
              <given-names>KD</given-names>
            </name>
          </person-group>
          <article-title>Altered Brain Structure in Irritable Bowel Syndrome: Potential Contributions of Pre-Existing and Disease-Driven Factors</article-title>
          <source>Gastroenterology</source>
          <year>2010</year>
          <volume>138</volume>
          <fpage>1783</fpage>
          <lpage>1789</lpage>
          <pub-id pub-id-type="pmid">20045701</pub-id>
        </element-citation>
      </ref>
      <ref id="CR42">
        <label>42.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gupta</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Sex-based differences in brain alterations across chronic pain conditions</article-title>
          <source>J. Neurosci. Res.</source>
          <year>2017</year>
          <volume>95</volume>
          <fpage>604</fpage>
          <lpage>616</lpage>
          <pub-id pub-id-type="pmid">27870423</pub-id>
        </element-citation>
      </ref>
      <ref id="CR43">
        <label>43.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Swann</surname>
              <given-names>JR</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Application of 1H NMR spectroscopy to the metabolic phenotyping of rodent brain extracts: A metabonomic study of gut microbial influence on host brain metabolism</article-title>
          <source>J. Pharm. Biomed. Anal.</source>
          <year>2017</year>
          <volume>143</volume>
          <fpage>141</fpage>
          <lpage>146</lpage>
          <pub-id pub-id-type="pmid">28595107</pub-id>
        </element-citation>
      </ref>
      <ref id="CR44">
        <label>44.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mudd</surname>
              <given-names>AT</given-names>
            </name>
            <name>
              <surname>Berding</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Donovan</surname>
              <given-names>SM</given-names>
            </name>
            <name>
              <surname>Dilger</surname>
              <given-names>RN</given-names>
            </name>
          </person-group>
          <article-title>Serum cortisol mediates the relationship between fecal Ruminococcus &amp; brain N-acetylaspartate in the young pig</article-title>
          <source>Gut Microbes</source>
          <year>2017</year>
          <volume>8</volume>
          <fpage>589</fpage>
          <lpage>600</lpage>
          <pub-id pub-id-type="pmid">28703640</pub-id>
        </element-citation>
      </ref>
      <ref id="CR45">
        <label>45.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mayer</surname>
              <given-names>EA</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Gut Microbes and the Brain: Paradigm Shift in Neuroscience</article-title>
          <source>J. Neurosci.</source>
          <year>2014</year>
          <volume>34</volume>
          <fpage>15490</fpage>
          <lpage>6</lpage>
          <pub-id pub-id-type="pmid">25392516</pub-id>
        </element-citation>
      </ref>
      <ref id="CR46">
        <label>46.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rieder</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Wisniewski</surname>
              <given-names>PJ</given-names>
            </name>
            <name>
              <surname>Alderman</surname>
              <given-names>BL</given-names>
            </name>
            <name>
              <surname>Campbell</surname>
              <given-names>SC</given-names>
            </name>
          </person-group>
          <article-title>Microbes and mental health: A review</article-title>
          <source>Brain. Behav. Immun.</source>
          <year>2017</year>
          <volume>66</volume>
          <fpage>9</fpage>
          <lpage>17</lpage>
          <pub-id pub-id-type="pmid">28131791</pub-id>
        </element-citation>
      </ref>
      <ref id="CR47">
        <label>47.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tillisch</surname>
              <given-names>K</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Brain structure and response to emotional stimuli as related to gut microbial profiles in healthy women</article-title>
          <source>Psychosomatic Medicine</source>
          <year>2017</year>
          <volume>79</volume>
          <fpage>905</fpage>
          <lpage>913</lpage>
          <pub-id pub-id-type="pmid">28661940</pub-id>
        </element-citation>
      </ref>
      <ref id="CR48">
        <label>48.</label>
        <mixed-citation publication-type="other">De Palma, G. <italic>et al</italic>. Transplantation of fecal microbiota from patients with irritable bowel syndrome alters gut function and behavior in recipient mice. <italic>Sci</italic>. <italic>Transl</italic>. <italic>Med</italic>. <bold>9</bold> (2017).</mixed-citation>
      </ref>
      <ref id="CR49">
        <label>49.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Labus</surname>
              <given-names>JS</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Differences in gut microbial composition correlate with regional brain volumes in irritable bowel syndrome</article-title>
          <source>Microbiome</source>
          <year>2017</year>
          <volume>5</volume>
          <fpage>49</fpage>
          <pub-id pub-id-type="pmid">28457228</pub-id>
        </element-citation>
      </ref>
      <ref id="CR50">
        <label>50.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fillingim</surname>
              <given-names>RB</given-names>
            </name>
            <name>
              <surname>King</surname>
              <given-names>CD</given-names>
            </name>
            <name>
              <surname>Ribeiro-Dasilva</surname>
              <given-names>MC</given-names>
            </name>
            <name>
              <surname>Rahim-Williams</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Riley</surname>
              <given-names>JL</given-names>
            </name>
          </person-group>
          <article-title>Sex, Gender, and Pain: A Review of Recent Clinical and Experimental Findings</article-title>
          <source>J. Pain</source>
          <year>2009</year>
          <volume>10</volume>
          <fpage>447</fpage>
          <lpage>485</lpage>
          <pub-id pub-id-type="pmid">19411059</pub-id>
        </element-citation>
      </ref>
      <ref id="CR51">
        <label>51.</label>
        <mixed-citation publication-type="other">Houghton, L. A. <italic>et al</italic>. Age, Gender and Women’s Health and the Patient. <italic>Gastroenterology</italic>, 10.1053/j.gastro.2016.02.017 (2016).</mixed-citation>
      </ref>
      <ref id="CR52">
        <label>52.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lueken</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Muehlhan</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Evens</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Wittchen</surname>
              <given-names>H-U</given-names>
            </name>
            <name>
              <surname>Kirschbaum</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Within and between session changes in subjective and neuroendocrine stress parameters during magnetic resonance imaging: A controlled scanner training study</article-title>
          <source>Psychoneuroendocrinology</source>
          <year>2017</year>
          <volume>37</volume>
          <fpage>1299</fpage>
          <lpage>1308</lpage>
        </element-citation>
      </ref>
      <ref id="CR53">
        <label>53.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zigmond</surname>
              <given-names>AS</given-names>
            </name>
            <name>
              <surname>Snaith</surname>
              <given-names>RP</given-names>
            </name>
          </person-group>
          <article-title>The Hospital Anxiety and Depression Scale</article-title>
          <source>Acta Psychiatr. Scand.</source>
          <year>1983</year>
          <volume>67</volume>
          <fpage>361</fpage>
          <lpage>370</lpage>
          <pub-id pub-id-type="pmid">6880820</pub-id>
        </element-citation>
      </ref>
      <ref id="CR54">
        <label>54.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Labus</surname>
              <given-names>JS</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The Visceral Sensitivity Index: development and validation of a gastrointestinal symptom-specific anxiety scale</article-title>
          <source>Aliment. Pharmacol. Ther.</source>
          <year>2004</year>
          <volume>20</volume>
          <fpage>89</fpage>
          <lpage>97</lpage>
          <pub-id pub-id-type="pmid">15225175</pub-id>
        </element-citation>
      </ref>
      <ref id="CR55">
        <label>55.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Francis</surname>
              <given-names>CY</given-names>
            </name>
            <name>
              <surname>Morris</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Whorwell</surname>
              <given-names>PJ</given-names>
            </name>
          </person-group>
          <article-title>The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress</article-title>
          <source>Aliment. Pharmacol. Ther.</source>
          <year>1997</year>
          <volume>11</volume>
          <fpage>395</fpage>
          <lpage>402</lpage>
          <pub-id pub-id-type="pmid">9146781</pub-id>
        </element-citation>
      </ref>
      <ref id="CR56">
        <label>56.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cleeland</surname>
              <given-names>CS</given-names>
            </name>
            <name>
              <surname>Ryan</surname>
              <given-names>KM</given-names>
            </name>
          </person-group>
          <article-title>Pain assessment: global use of the Brief Pain Inventory</article-title>
          <source>Ann. Acad. Med. Singapore</source>
          <year>1994</year>
          <volume>23</volume>
          <fpage>129</fpage>
          <lpage>138</lpage>
          <pub-id pub-id-type="pmid">8080219</pub-id>
        </element-citation>
      </ref>
      <ref id="CR57">
        <label>57.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mullins</surname>
              <given-names>PG</given-names>
            </name>
            <name>
              <surname>Rowland</surname>
              <given-names>LM</given-names>
            </name>
            <name>
              <surname>Jung</surname>
              <given-names>RE</given-names>
            </name>
            <name>
              <surname>Sibbitt</surname>
              <given-names>WL</given-names>
            </name>
          </person-group>
          <article-title>A novel technique to study the brain’s response to pain: Proton magnetic resonance spectroscopy</article-title>
          <source>Neuroimage</source>
          <year>2005</year>
          <volume>26</volume>
          <fpage>642</fpage>
          <lpage>646</lpage>
          <pub-id pub-id-type="pmid">15907322</pub-id>
        </element-citation>
      </ref>
      <ref id="CR58">
        <label>58.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mescher</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Merkle</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Kirsch</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Garwood</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Gruetter</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Simultaneous <italic>in vivo</italic> spectral editing and water suppression</article-title>
          <source>NMR Biomed.</source>
          <year>1998</year>
          <volume>11</volume>
          <fpage>266</fpage>
          <lpage>272</lpage>
          <pub-id pub-id-type="pmid">9802468</pub-id>
        </element-citation>
      </ref>
      <ref id="CR59">
        <label>59.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Klose</surname>
              <given-names>U</given-names>
            </name>
          </person-group>
          <article-title><italic>In vivo</italic> proton spectroscopy in presence of eddy currents</article-title>
          <source>Magn. Reson. Med.</source>
          <year>1990</year>
          <volume>14</volume>
          <fpage>26</fpage>
          <lpage>30</lpage>
          <pub-id pub-id-type="pmid">2161984</pub-id>
        </element-citation>
      </ref>
      <ref id="CR60">
        <label>60.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Provencher</surname>
              <given-names>SW</given-names>
            </name>
          </person-group>
          <article-title>Estimation of metabolite concentrations from localized <italic>in vivo</italic> proton NMR spectra</article-title>
          <source>Magn. Reson. Med.</source>
          <year>1993</year>
          <volume>30</volume>
          <fpage>672</fpage>
          <lpage>679</lpage>
          <pub-id pub-id-type="pmid">8139448</pub-id>
        </element-citation>
      </ref>
      <ref id="CR61">
        <label>61.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Edden</surname>
              <given-names>RAE</given-names>
            </name>
            <name>
              <surname>Puts</surname>
              <given-names>NAJ</given-names>
            </name>
            <name>
              <surname>Barker</surname>
              <given-names>PB</given-names>
            </name>
          </person-group>
          <article-title>Macromolecule-suppressed GABA-edited magnetic resonance spectroscopy at 3T</article-title>
          <source>Magn. Reson. Med.</source>
          <year>2012</year>
          <volume>68</volume>
          <fpage>657</fpage>
          <lpage>661</lpage>
          <pub-id pub-id-type="pmid">22777748</pub-id>
        </element-citation>
      </ref>
      <ref id="CR62">
        <label>62.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Govind</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Young</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Maudsley</surname>
              <given-names>AA</given-names>
            </name>
          </person-group>
          <article-title>Corrigendum: proton NMR chemical shifts and coupling constants for brain metabolites. Govindaraju V, Young K, Maudsley AA, NMR Biomed. 2000; 13: 129-153</article-title>
          <source>NMR in biomedicine</source>
          <year>2015</year>
          <volume>28</volume>
          <fpage>923</fpage>
          <lpage>924</lpage>
          <pub-id pub-id-type="pmid">26094860</pub-id>
        </element-citation>
      </ref>
      <ref id="CR63">
        <label>63.</label>
        <mixed-citation publication-type="other">Sanaei Nezhad, F. <italic>et al</italic>. Quantification of GABA, glutamate and glutamine in a single measurement at 3 T using GABA-edited MEGA-PRESS. <italic>NMR Biomed</italic>. <bold>31</bold> (2018).</mixed-citation>
      </ref>
      <ref id="CR64">
        <label>64.</label>
        <mixed-citation publication-type="other">Currie, S. <italic>et al</italic>. Magnetic resonance spectroscopy of the brain. <italic>Postgrad</italic>. <italic>Med</italic>. <italic>J</italic>. <bold>89</bold>, 94 LP–106 (2013).</mixed-citation>
      </ref>
      <ref id="CR65">
        <label>65.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chang</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Munsaka</surname>
              <given-names>SM</given-names>
            </name>
            <name>
              <surname>Kraft-Terry</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Ernst</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Magnetic resonance spectroscopy to assess neuroinflammation and neuropathic pain</article-title>
          <source>J. Neuroimmune Pharmacol.</source>
          <year>2013</year>
          <volume>8</volume>
          <fpage>576</fpage>
          <lpage>593</lpage>
          <pub-id pub-id-type="pmid">23666436</pub-id>
        </element-citation>
      </ref>
      <ref id="CR66">
        <label>66.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zahr</surname>
              <given-names>NM</given-names>
            </name>
            <name>
              <surname>Mayer</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Rohlfing</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Sullivan</surname>
              <given-names>EV</given-names>
            </name>
            <name>
              <surname>Pfefferbaum</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Imaging neuroinflammation? A perspective from MR spectroscopy</article-title>
          <source>Brain Pathol.</source>
          <year>2014</year>
          <volume>24</volume>
          <fpage>654</fpage>
          <lpage>664</lpage>
          <pub-id pub-id-type="pmid">25345895</pub-id>
        </element-citation>
      </ref>
      <ref id="CR67">
        <label>67.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dydak</surname>
              <given-names>U</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title><italic>In vivo</italic> measurement of brain GABA concentrations by magnetic resonance spectroscopy in smelters occupationally exposed to manganese</article-title>
          <source>Environ. Health Perspect.</source>
          <year>2011</year>
          <volume>119</volume>
          <fpage>219</fpage>
          <lpage>224</lpage>
          <pub-id pub-id-type="pmid">20876035</pub-id>
        </element-citation>
      </ref>
      <ref id="CR68">
        <label>68.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Freire</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Mangin</surname>
              <given-names>J-F</given-names>
            </name>
          </person-group>
          <article-title>Motion Correction Algorithms May Create Spurious Brain Activations in the Absence of Subject Motion</article-title>
          <source>Neuroimage</source>
          <year>2001</year>
          <volume>14</volume>
          <fpage>709</fpage>
          <lpage>722</lpage>
          <pub-id pub-id-type="pmid">11506543</pub-id>
        </element-citation>
      </ref>
      <ref id="CR69">
        <label>69.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Freire</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Roche</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Mangin</surname>
              <given-names>JF</given-names>
            </name>
          </person-group>
          <article-title>What is the best similarity measure for motion correction in fMRI time series?</article-title>
          <source>IEEE Transactions on Medical Imaging</source>
          <year>2002</year>
          <volume>21</volume>
          <fpage>470</fpage>
          <lpage>484</lpage>
          <pub-id pub-id-type="pmid">12071618</pub-id>
        </element-citation>
      </ref>
      <ref id="CR70">
        <label>70.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Whitfield-Gabrieli</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Nieto-Castanon</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Conn: a functional connectivity toolbox for correlated and anticorrelated brain networks</article-title>
          <source>Brain Connect.</source>
          <year>2012</year>
          <volume>2</volume>
          <fpage>125</fpage>
          <lpage>141</lpage>
          <pub-id pub-id-type="pmid">22642651</pub-id>
        </element-citation>
      </ref>
      <ref id="CR71">
        <label>71.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Goldstein</surname>
              <given-names>JM</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Hypothalamic abnormalities in schizophrenia: sex effects and genetic vulnerability</article-title>
          <source>Biol. Psychiatry</source>
          <year>2007</year>
          <volume>61</volume>
          <fpage>935</fpage>
          <lpage>945</lpage>
          <pub-id pub-id-type="pmid">17046727</pub-id>
        </element-citation>
      </ref>
      <ref id="CR72">
        <label>72.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Frazier</surname>
              <given-names>JA</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Structural brain magnetic resonance imaging of limbic and thalamic volumes in pediatric bipolar disorder</article-title>
          <source>Am. J. Psychiatry</source>
          <year>2005</year>
          <volume>162</volume>
          <fpage>1256</fpage>
          <lpage>1265</lpage>
          <pub-id pub-id-type="pmid">15994707</pub-id>
        </element-citation>
      </ref>
      <ref id="CR73">
        <label>73.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Makris</surname>
              <given-names>N</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Decreased volume of left and total anterior insular lobule in schizophrenia</article-title>
          <source>Schizophr. Res.</source>
          <year>2006</year>
          <volume>83</volume>
          <fpage>155</fpage>
          <lpage>171</lpage>
          <pub-id pub-id-type="pmid">16448806</pub-id>
        </element-citation>
      </ref>
      <ref id="CR74">
        <label>74.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Desikan</surname>
              <given-names>RS</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest</article-title>
          <source>Neuroimage</source>
          <year>2006</year>
          <volume>31</volume>
          <fpage>968</fpage>
          <lpage>980</lpage>
          <pub-id pub-id-type="pmid">16530430</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
